Skin

Narrowband‐Ultraviolet B Phototherapy for Psoriasis Treatment in Skin of Color

Photodermatology, Photoimmunology & Photomedicine

This systematic review article concluded that narrowband phototherapy is effective for the treatment of psoriasis in patients with skin of color. These findings are significant given that evaluation and treatment of dermatological conditions in skin of color is an understudied field. Of the studies evaluated in this review, 70.5% of patients achieved PASI75, a benchmark for successful psoriasis therapy where patients see a 75% reduction in their PASI score, and all studies demonstrated statistically significant PASI improvement after treatment.

Related Studies

Skin

Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response

Journal of Allergy and Clinical Immunology

This study found that narrowband UVB light therapy reduced the severity score of atopic dermatitis, a common inflammatory skin disease, by at least 50% for all subjects. The study then looked at the mechanisms of action and found that UVB light therapy suppressed inflammatory Th2 and T22 immune cells and normalized expression of skin barrier proteins to reduce skin thickening due to overactive keratinocytes.

Skin

Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response

Journal of Allergy and Clinical Immunology

This study found that narrowband UVB light therapy reduced the severity score of atopic dermatitis, a common inflammatory skin disease, by at least 50% for all subjects. The study then looked at the mechanisms of action and found that UVB light therapy suppressed inflammatory Th2 and T22 immune cells and normalized expression of skin barrier proteins to reduce skin thickening due to overactive keratinocytes.

Skin

Phototherapy in Psoriasis: A Review of Mechanisms of Action

Journal of Cutaneous Medicine and Surgery

This review provides a summary of the mechanisms thought to be responsible for the therapeutic effects of phototherapy for psoriasis. These mechanisms include through the alteration of the cytokine profile to shift immune response away from inflammatory pathways, through the induction of apoptosis of cells found in psoriasis lesions, and through the promotion of immunosuppression.

Skin

Phototherapy in Psoriasis: A Review of Mechanisms of Action

Journal of Cutaneous Medicine and Surgery

This review provides a summary of the mechanisms thought to be responsible for the therapeutic effects of phototherapy for psoriasis. These mechanisms include through the alteration of the cytokine profile to shift immune response away from inflammatory pathways, through the induction of apoptosis of cells found in psoriasis lesions, and through the promotion of immunosuppression.

Skin

Comparison of Efficacy of Narrow Band Ultraviolet B Phototherapy With Emollients in Uremic Pruritus Patients at Tertiary Care Hospital

The Professional Medical Journal

Pruritus, severe itching of the skin, is a common, irritating symptom associated with chronic kidney disease. This study compared the use of narrowband UV light therapy to the use of medical moisturizers in hemodialysis patients and found that UVB light therapy was more effective at lowering itch score in this patient population. The UVB treatment group saw a statistically reduction of itch-score of more than half from baseline levels.

Skin

Comparison of Efficacy of Narrow Band Ultraviolet B Phototherapy With Emollients in Uremic Pruritus Patients at Tertiary Care Hospital

The Professional Medical Journal

Pruritus, severe itching of the skin, is a common, irritating symptom associated with chronic kidney disease. This study compared the use of narrowband UV light therapy to the use of medical moisturizers in hemodialysis patients and found that UVB light therapy was more effective at lowering itch score in this patient population. The UVB treatment group saw a statistically reduction of itch-score of more than half from baseline levels.

HSA/FSA Eligible

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) UVB light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

HSA/FSA Eligible

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) UVB light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

HSA/FSA Eligible

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) UVB light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.